Join to View Full Profile
600 N Cattlemen RdSuite 200Sarasota, FL 34232
Phone+1 941-377-9993
Fax+1 941-343-0026
Are you Dr. Patel?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Manish Patel, MD is an oncologist in Sarasota, Florida. He is currently licensed to practice medicine in Florida.
Education & Training
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
Vanderbilt University Medical CenterResidency, Internal Medicine, 2005 - 2008
University of Miami Leonard M. Miller School of MedicineClass of 2005
Certifications & Licensure
FL State Medical License 2009 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies.Jan Philipp Bewersdorf, Xiaoli Mi, Bin Lu, Andrew Kuykendall, David Sallman
Leukemia. 2025-03-01 - Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma.Steven M Horwitz, Tatyana A Feldman, Jing Christine Ye, Michael S Khodadoust, Javier Munoz
Leukemia & Lymphoma. 2025-02-08 - 1 citationsPirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial.Nirav N Shah, Michael Wang, Lindsey E Roeker, Krish Patel, Jennifer A Woyach
Haematologica. 2025-01-01
Press Mentions
Groundbreaking New FDA-Approved Drug for Acute Leukemia First Administered at Florida Cancer Specialists & Research Institute Sarasota Drug Development UnitNovember 22nd, 2024- Florida Cancer Specialists & Research Institute Presents Clinical Research Results at 2022 ASCO® Annual MeetingJune 3rd, 2022
- Sarah Cannon to Present Latest Cancer Research Insights at 2021 ASCO® Annual MeetingJune 4th, 2021
- Join now to see all
